Integrated cross-species transcriptional network analysis of metastatic susceptibility

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 8, 2012, Pages 3184-3189

  Hu, Ying ^a   Wu, Gang ^b   Rusch, Michael ^b   Lukes, Luanne ^a   Buetow, Kenneth H ^a   Zhang, Jinghui ^b   Hunter, Kent W ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

Gene expression; Mouse models

Indexed keywords

ESTROGEN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER SUSCEPTIBILITY; CELL CYCLE CHECKPOINT; DATA BASE; DISTANT METASTASIS FREE SURVIVAL; GENETIC CONSERVATION; HUMAN; METASTASIS; METASTASIS POTENTIAL; MITOSIS SPINDLE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PREDICTIVE VALUE; PRIORITY JOURNAL; SPECIES DIFFERENCE; TUMOR CELL;

ANIMALS; ANTIGENS, CD53; BREAST NEOPLASMS; CELL CYCLE PROTEINS; CELL LINE, TUMOR; DATABASES, GENETIC; DISEASE PROGRESSION; DISEASE SUSCEPTIBILITY; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; HUMANS; KAPLAN-MEIER ESTIMATE; MICE; MICROTUBULE-ASSOCIATED PROTEINS; NEOPLASM METASTASIS; NUCLEAR PROTEINS; RECEPTORS, ESTROGEN; SPECIES SPECIFICITY;

EID: 84863157850     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1117872109     Document Type: Article

References (44)

1. Perou CM, et al. (2000) Molecular portraits of human breast tumours. Nature 406:747-752.
2. Driouch K, Landemaine T, Sin S, Wang S, Lidereau R (2007) Gene arrays for diagnosis, prognosis and treatment of breast cancer metastasis. Clin Exp Metastasis 24:575-585.
3. Ein-Dor L, Kela I, Getz G, Givol D, Domany E (2005) Outcome signature genes in breast cancer: Is there a unique set? Bioinformatics 21:171-178.
4. Ein-Dor L, Zuk O, Domany E (2006) Thousands of samples are needed to generate a robust gene list for predicting outcome in cancer. Proc Natl Acad Sci USA 103:5923-5928.
5. Schadt EE, et al. (2005) An integrative genomics approach to infer causal associations between gene expression and disease. Nat Genet 37:710-717.
6. Quigley DA, et al. (2009) Genetic architecture of mouse skin inflammation and tumour susceptibility. Nature 458:505-508.
7. Ringnér M, Fredlund E, Häkkinen J, Borg A, Staaf J (2011) GOBO: Gene expression-based outcome for breast cancer online. PLoS ONE 6:e17911.
8. Wang Y, et al. (2005) Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 365:671-679.
9. Schmidt M, et al. (2008) The humoral immune system has a key prognostic impact in node-negative breast cancer. Cancer Res 68:5405-5413.
10. Guy CT, Cardiff RD, Muller WJ (1992) Induction of mammary tumors by expression of polyomavirus middle T oncogene: A transgenic mouse model for metastatic disease. Mol Cell Biol 12:954-961.
11. Hunter KW, et al. (2001) Predisposition to efficient mammary tumor metastatic progression is linked to the breast cancer metastasis suppressor gene Brms1. Cancer Res 61:8866-8872.
12. Yang H, et al. (2004) Caffeine suppresses metastasis in a transgenic mouse model: A prototype molecule for prophylaxis of metastasis. Clin Exp Metastasis 21:719-735.
13. Li A, Horvath S (2009) Network module detection: Affinity search technique with the multi-node topological overlap measure. BMC Res Notes 2:142.
14. van de Vijver MJ, et al. (2002) A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347:1999-2009.
15. Tang Z, Shu H, Oncel D, Chen S, Yu H (2004) Phosphorylation of Cdc20 by Bub1 provides a catalytic mechanism for APC/C inhibition by the spindle checkpoint. Mol Cell 16:387-397.
16. Reddy SK, Rape M, Margansky WA, Kirschner MW (2007) Ubiquitination by the anaphase-promoting complex drives spindle checkpoint inactivation. Nature 446:921-925.
17. Pei XF, et al. (2004) Explant-cell culture of primary mammary tumors from MMTV-c-Myc transgenic mice. In Vitro Cell Dev Biol Anim 40:14-21.
18. Lukes L, Crawford NP, Walker R, Hunter KW (2009) The origins of breast cancer prognostic gene expression profiles. Cancer Res 69:310-318.
19. Crawford NP, et al. (2008) Bromodomain 4 activation predicts breast cancer survival. Proc Natl Acad Sci USA 105:6380-6385.
20. Alsarraj J, et al. (2011) Deletion of the proline-rich region of the murine metastasis susceptibility gene Brd4 promotes epithelial-to-mesenchymal transition- and stem cell-like conversion. Cancer Res 71:3121-3131.
21. van 't Veer LJ, et al. (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature 415:530-536.
22. Sotiriou C, et al. (2006) Gene expression profiling in breast cancer: Understanding the molecular basis of histologic grade to improve prognosis. J Natl Cancer Inst 98:262-272.
23. Liu YY, Slotine JJ, Barabási AL (2011) Controllability of complex networks. Nature 473:167-173.
24. Cozma D, et al. (2002) A bioinformatics-based strategy identifies c-Myc and Cdc25A as candidates for the Apmt mammary tumor latency modifiers. Genome Res 12:969-975.
25. Crawford NP, et al. (2007) Rrp1b, a new candidate susceptibility gene for breast cancer progression and metastasis. PLoS Genet 3:e214.
26. Maruyama T, et al. (2002) A mammalian bromodomain protein, brd4, interacts with replication factor C and inhibits progression to S phase. Mol Cell Biol 22:6509-6520.
27. Rahman S, et al. (2011) The Brd4 extraterminal domain confers transcription activation independent of pTEFb by recruiting multiple proteins, including NSD3. Mol Cell Biol 31:2641-2652.
28. Lau NC, et al. (2009) Human Ccr4-Not complexes contain variable deadenylase subunits. Biochem J 422:443-453.
29. Elishmereni M, Levi-Schaffer F (2011) CD48: A co-stimulatory receptor of immunity. Int J Biochem Cell Biol 43:25-28.
30. Bos SD, et al. (2010) A genome-wide linkage scan reveals CD53 as an important regulator of innate TNF-alpha levels. Eur J Hum Genet 18:953-959.
31. Finak G, et al. (2008) Stromal gene expression predicts clinical outcome in breast cancer. Nat Med 14:518-527.
32. Teschendorff AE, Miremadi A, Pinder SE, Ellis IO, Caldas C (2007) An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer. Genome Biol 8:R157.
33. Alsarraj J, et al. (2011) Deletion of the proline-rich region of the murine metastasis susceptibility gene Brd4 promotes epithelial-to-mesenchymal transition- and stem cell-like conversion. Cancer Res 71:3121-3131.
34. Crawford NP, et al. (2008) The diasporin pathway: A tumor progression-related transcriptional network that predicts breast cancer survival. Clin Exp Metastasis 25:357-369.
35. Park YG, et al. (2005) Sipa1 is a candidate for underlying the metastasis efficiency modifier locus Mtes1. Nat Genet 37:1055-1062.
36. Hsieh SM, Look MP, Sieuwerts AM, Foekens JA, Hunter KW (2009) Distinct inherited metastasis susceptibility exists for different breast cancer subtypes: A prognosis study. Breast Cancer Res 11:R75.
37. Churchill GA, et al.; Complex Trait Consortium (2004) The Collaborative Cross, a community resource for the genetic analysis of complex traits. Nat Genet 36:1133-1137.
38. Yang H, et al. (2005) Metastasis predictive signature profiles pre-exist in normal tissues. Clin Exp Metastasis 22:593-603.
39. Thierry-Mieg D, Thierry-Mieg J (2006) AceView: A comprehensive cDNA-supported gene and transcripts annotation. Genome Biol 7(Suppl 1):S12.1-S12.14.
40. Florea L, Hartzell G, Zhang Z, Rubin GM, Miller W (1998) A computer program for aligning a cDNA sequence with a genomic DNA sequence. Genome Res 8:967-974.
41. Mortazavi A, Williams BA, McCue K, Schaeffer L, Wold B (2008) Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat Methods 5:621-628.
42. Wright GW, Simon RM (2003) A random variance model for detection of differential gene expression in small microarray experiments. Bioinformatics 19:2448-2455.
43. Langfelder P, Horvath S (2008) WGCNA: An R package for weighted correlation network analysis. BMC Bioinformatics 9:559.
44. Shannon P, et al. (2003) Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome Res 13:2498-2504.